Stay updated on ARO-ENaC in Healthy Volunteers & Cystic Fibrosis Clinical Trial
Sign up to get notified when there's something new on the ARO-ENaC in Healthy Volunteers & Cystic Fibrosis Clinical Trial page.

Latest updates to the ARO-ENaC in Healthy Volunteers & Cystic Fibrosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous notices including the government funding lapse notice and the Revision: v3.4.1 entry.SummaryDifference0.4%

- Check22 days agoChange DetectedA site-wide funding notice about a lapse in government funding was added, noting the NIH Clinical Center is open and directing users to opm.gov for status. A revision tag showing v3.4.1 was added, replacing the previous v3.4.0.SummaryDifference0.4%

- Check29 days agoChange DetectedA 'Show glossary' option was added and several date fields were updated (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) with the 'Estimated' labels removed. The No FEAR Act data label was changed and the site revision shown on the page updated to v3.4.0.SummaryDifference0.3%

- Check43 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed. This is a site version update and does not change the study content or how a user interacts with the page.SummaryDifference0.0%

- Check64 days agoChange DetectedResults posted (2025-12-17) and Phase 2 details were added, along with new Research Site locations and CF/healthy volunteer arms. The page now includes Study Protocol and Statistical Analysis Plan documents and expanded dosing/regimen information.SummaryDifference10%

- Check92 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.1%

Stay in the know with updates to ARO-ENaC in Healthy Volunteers & Cystic Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-ENaC in Healthy Volunteers & Cystic Fibrosis Clinical Trial page.